Co-infection and Cancer (R01 Clinical Trial Not Allowed)

This initiative seeks to enhance the mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. The National Institutes of Health is accepting applications for this grant, with a focus on co-infections that engender novel opportunities for prevention and treatment, particularly in understudied populations. Some key points to consider include: • The grant is focused on co-infections, excluding co-infection with human immunodeficiency virus (HIV). • The grant is open to a variety of applicant types, including small businesses, private institutions of higher education, and state governments. • The grant has a closing date of January 7, 2026. • The grant is expected to fund several projects, with an expected application count of 100.